N/A
N=422
Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication
End-stage Renal Disease · Chronic Kidney Diseases
Bottom Line
View on ClinicalTrials.gov: NCT05154773 ↗Enrolled (actual)
422
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Living Donor Inquiry — 16.0; 18.6 Percentage of participants — p=0.507
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Kidney donation and transplant information made easy (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- State University of New York at Buffalo
- Primary completion
- Sep 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Living Donor Inquiry |
16.0; 18.6 | 0.507 |
| SECONDARY Living Donor Kidney Transplant Knowledge |
11.1; 10.4; 11.1; 10.4; 11.0; 10.6 | 0.0002 sig |
| SECONDARY Living Donor Kidney Transplant Concerns |
10.7; 11.2; 11.1; 11.6; 11.2; 11.9 | 0.1136 |
| SECONDARY Living Donor Kidney Transplant Readiness |
2.7; 2.5; 2.8; 1.7; 2.8; 2.6 | 0.1443 |
| SECONDARY Number of Participants With at Least One New Living Donor Kidney Transplant Access Behavior |
78; 54 | 0.008 sig |
Summary
The study is a- 2-arm randomized controlled trial among patients presenting for kidney transplant evaluation at a single transplant center to compare the effects of a patient-based self-learning and outreach intervention about living-donor kidney transplantation (KidneyTIME) versus usual care for living-donor kidney transplant knowledge, concerns, readiness, access behaviors, and living-donor inquiries over 12 months follow-up. Following consent and baseline assessment, participants were randomized, stratified by self-reported race, with equal allocation to 2 treatment arms: the KidneyTIME intervention and usual care.
Eligibility Criteria
Inclusion Criteria
- referred to the transplant center for a kidney transplant
- aged 18 years and older
- speaks English
- has access to the internet
Exclusion Criteria
- Previously exposed to any component of the intervention
Data sourced from ClinicalTrials.gov (NCT05154773). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.